Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
Argus Health
Mallinckrodt
Merck
Novartis
Cerilliant
Harvard Business School
UBS
Julphar

Generated: January 24, 2018

DrugPatentWatch Database Preview

Methyclothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methyclothiazide and what is the scope of methyclothiazide freedom to operate?

Methyclothiazide
is the generic ingredient in five branded drugs marketed by Medpointe Pharm Hlc, Abbvie, Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Sandoz, Usl Pharma, Watson Labs, and Abbott, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for methyclothiazide. One supplier is listed for this compound.
Summary for methyclothiazide
Pharmacology for methyclothiazide
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for methyclothiazide

US Patents and Regulatory Information for methyclothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 089837-001 Aug 18, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott EUTRON methyclothiazide; pargyline hydrochloride TABLET;ORAL 016047-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ENDURON methyclothiazide TABLET;ORAL 012524-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 089835-001 Aug 18, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 088750-001 Sep 6, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ENDURON methyclothiazide TABLET;ORAL 012524-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 087671-001 Aug 17, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 089135-001 Feb 12, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 087672-001 Aug 17, 1982 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma METHYCLOTHIAZIDE methyclothiazide TABLET;ORAL 088745-001 Mar 21, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Moodys
Cantor Fitzgerald
Farmers Insurance
Citi
Accenture
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot